Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian R Schulz

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Lancet. Microbe|June 6, 2025
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
European Journal of Immunology|March 7, 2022
Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodiesSebastian R Schulz, Markus Hoffmann, Edith Roth, et al.
Cell Reports|August 14, 2020
B Cell Speed and B-FDC Contacts in Germinal Centers Determine Plasma Cell Output via Swiprosin-1/EFhd2Dorothea Reimer, Michael Meyer-Hermann, Asylkhan Rakhymzhan, et al.
Viruses|November 11, 2022
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, et al.
Cell Communication and Signaling : CCS|February 18, 2025
IgA displays site- and subclass-specific glycoform differences despite equal glycoenzyme expressionDavid Falck, Maria V Sokolova, Carolien A M Koeleman, et al.
European Journal of Immunology|September 21, 2021
A surrogate cell-based SARS-CoV-2 spike blocking assayWolfgang Schuh, Lena Baus, Tobit Steinmetz, et al.
Cell Reports|February 10, 2024
GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunityTheresa E H Bierling, Amelie Gumann, Shannon R Ottmann, et al.
Virology|September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variantLu Zhang, Amy Kempf, Inga Nehlmeier, et al.
The Lancet. Infectious Diseases|September 18, 2022
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75Prerna Arora, Inga Nehlmeier, Amy Kempf, et al.
Vaccines|November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Lancet. Microbe|June 6, 2025
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
European Journal of Immunology|March 7, 2022
Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodiesSebastian R Schulz, Markus Hoffmann, Edith Roth, et al.
Cell Reports|August 14, 2020
B Cell Speed and B-FDC Contacts in Germinal Centers Determine Plasma Cell Output via Swiprosin-1/EFhd2Dorothea Reimer, Michael Meyer-Hermann, Asylkhan Rakhymzhan, et al.
Viruses|November 11, 2022
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, et al.
Cell Communication and Signaling : CCS|February 18, 2025
IgA displays site- and subclass-specific glycoform differences despite equal glycoenzyme expressionDavid Falck, Maria V Sokolova, Carolien A M Koeleman, et al.
European Journal of Immunology|September 21, 2021
A surrogate cell-based SARS-CoV-2 spike blocking assayWolfgang Schuh, Lena Baus, Tobit Steinmetz, et al.
Cell Reports|February 10, 2024
GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunityTheresa E H Bierling, Amelie Gumann, Shannon R Ottmann, et al.
Virology|September 9, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variantLu Zhang, Amy Kempf, Inga Nehlmeier, et al.
The Lancet. Infectious Diseases|September 18, 2022
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75Prerna Arora, Inga Nehlmeier, Amy Kempf, et al.
Vaccines|November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Pageof 5